2012-10-09 00:18:45 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Colby Pharmaceutical Company - Product Pipeline Review - 2012" provides data on the Colby Pharmaceutical Company's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Colby Pharmaceutical Company's corporate website, SEC filings, investor presentations and featured press releases, both from Colby Pharmaceutical Company and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Colby Pharmaceutical Company - Brief Colby Pharmaceutical Company overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current

pipeline of Colby Pharmaceutical Company human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Colby Pharmaceutical Company with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Colby Pharmaceutical Company's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468548_colby_pharmaceutical_company_product_ ..


Reasons to buy

* Evaluate Colby Pharmaceutical Company's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Colby Pharmaceutical Company.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Colby Pharmaceutical Company and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Colby Pharmaceutical Company Snapshot
Colby Pharmaceutical Company Overview
Key Information
Key Facts
Colby Pharmaceutical Company - Research and Development Overview
Key Therapeutic Areas
Colby Pharmaceutical Company - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Colby Pharmaceutical Company - Pipeline Products Glance
Colby Pharmaceutical Company Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Colby Pharmaceutical Company - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Colby Pharmaceutical Company - Drug Profiles
APC-100
Product Description
Mechanism of Action
R&D Progress
APC-200
Product Description
Mechanism of Action
R&D Progress
APC-300
Product Description
Mechanism of Action
R&D Progress
CPC-410
Product Description
Mechanism of Action
R&D Progress
JVRS-100
Product Description
Mechanism of Action
R&D Progress
JVRS-100 + Fluzone
Product Description
Mechanism of Action
R&D Progress
JVRS-100 + HBV Vaccine
Product Description
Mechanism of Action
R&D Progress
JVRS-100 + HSV-2 Vaccine
Product Description
Mechanism of Action
R&D Progress
JVRS-100 + Malaria Vaccine
Product Description
Mechanism of Action
R&D Progress
JVRS-100 + Pandemic Flu Vaccine
Product Description
Mechanism of Action
R&D Progress
JVRS-100 + Universal Influenza Vaccine
Product Description
Mechanism of Action
R&D Progress
Colby Pharmaceutical Company - Pipeline Products by Route of Administration
Colby Pharmaceutical Company - Pipeline Products By Mechanism of Action
Colby Pharmaceutical Company - Recent Pipeline Updates
Colby Pharmaceutical Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Colby Pharmaceutical Company, Recent Developments
Colby Pharmaceutical Company- Press Release
Jan 09, 2012: Colby Pharmaceutical Company Announces Publication Of JVRS-100's Use As Potent Immune Activating Adjuvant In Combination With H5N1 Influenza Vaccine
Nov 02, 2009: Juvaris BioTherapeutics Initiates Phase II Study Of Influenza Vaccine Adjuvant In Elderly Population.
May 08, 2009: Juvaris BioTherapeutics' Universal Influenza Vaccine Protects from Lethal H1N1 and H3N2 Challenges in Pre-Clinical Studies
Apr 27, 2009: Juvaris BioTherapeutics' Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses To Influenza In Clinical Trial
Jan 08, 2009: Juvaris BioTherapeutics Announces Positive Data From Clinical Trial Of JVRS-100 Adjuvanted Flu Vaccine
Financial Deals Landscape
Colby Pharmaceutical Company, Deals Summary
Colby Pharmaceutical Company, Pharmaceuticals & Healthcare, Deal Details
Licensing Agreements
Juvaris Enters Into Licensing Agreement With Colby Pharma For JVRS-100 And CLDC Technology
Adamis Pharma Enters Into Licensing Agreement With Colby Pharma
Appendix

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468548&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.